Notch Signaling in Cancer: Rationale and Strategies for Targeting

Author(s): Aisha Alketbi, Samir Attoub

Journal Name: Current Cancer Drug Targets

Volume 15 , Issue 5 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


The Notch signaling pathway is a highly conserved system that controls embryonic cell fate decisions and the maintenance of adult stem cells through affecting communication between adjacent cells. The pathway is linked to the development of various cancers owing to increased cell proliferation and tumor blood perfusion in addition to inhibition of apoptosis. Pharmaceutical agents that suppress overactive Notch signaling may be of benefit in the treatment of patients with various cancers. These targeted therapies confer several advantages over conventional anticancer therapies including reduced deleterious effects on normal cells. In this review, we explore the rationale for targeting the Notch signaling pathway in cancer along with different investigational strategies designed to block the pathway.

Keywords: Cancer, monoclonal antibodies, notch inhibitors, notch signaling, γ-secretase inhibitors.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 09 July, 2015
Page: [364 - 374]
Pages: 11
DOI: 10.2174/156800961505150710113353
Price: $65

Article Metrics

PDF: 69
PRC: 1